Skip to main content

1Provenance card

the boundary, as counts

Sources

3225 with DOI

20 strong · 8 moderate · 4 weak

Compilations

12026-05-11T11:15:59.053Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

23last ruled 2026-06-04

0 awaiting a ruling

Issued documents

52026-10-19T20:34:12.142Z

notice · info card · emergency

Searches

130 with no results

queries and counts on the build

Claims checked

7714 supported

14 supported · 63 not

Correspondence

0received

consent field ships in Phase 4

Edges

237

derivations recorded for this entity

Complete over 32 sources, 1 compilation, and 23 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/thcv/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-09-07srcBeneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson’s disease
  4. 2026-09-07srcPure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages
  5. 2026-09-07srcSimilarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
  6. 2026-09-07srcPhytocannabinoids: Origins and Biosynthesis
  7. 2026-09-07srcEffects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes
  8. 2026-09-07srcThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin
  9. 2026-09-07srcThe CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers
  10. 2026-09-07srcAre cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
  11. 2026-09-07srcThe phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects
  12. 2026-09-07srcA systematic review of minor phytocannabinoids with promising neuroprotective potential.
  13. 2026-09-07srcThe plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
  14. 2026-09-07srcEffects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
  15. 2026-09-07srcΔ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors
  16. 2026-09-07srcΔ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
  17. 2026-09-07srcTRPV3 activation by different agonists accompanied by lipid dissociation from the vanilloid site
  18. 2026-09-07srcThe biosynthesis of the cannabinoids
  19. 2026-09-07srcEfficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
  20. 2026-09-07srcWeight Loss and Therapeutic Metabolic Effects of Tetrahydrocannabivarin (THCV)-Infused Mucoadhesive Strips
  21. 2026-09-07srcMinor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
  22. 2026-09-07srcCannabis sativa: The Plant of the Thousand and One Molecules
  23. 2026-09-07srcThe Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No Strain, No Gain
  24. 2026-09-07srcEffects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes
  25. 2026-09-07srcRare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling Pathway
  26. 2026-09-07srcThe role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
  27. 2026-09-07srcHair Regrowth with Novel Hemp Extract: A Case Series
  28. 2026-09-07srcEvidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist
  29. 2026-09-07srcThe psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
  30. 2026-09-07srcSynthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
  31. 2026-09-07srcTHCV (Tetrahydrocannabivarin) — PubChem CID 93147
  32. 2026-09-07srcPharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants
  33. 2026-09-07srcTHCV Legal Status by Country 2025: Canada, EU, Australia
  34. 2026-09-07srcTetrahydrocannabivarin — Wikipedia
  35. 2026-09-04issueIssued emergency
  36. 2026-09-04issueIssued info_card
  37. 2026-09-04issueIssued notice
  38. 2026-06-04proposal21 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  39. 2026-06-04publicationPublication — backfill
  40. 2026-05-11revisionRevision 1
  41. 2026-05-11genGeneration — pipeline-v5 · with 4 morepipeline-v5
  42. 2026-05-11rungeneration run

The same entries, as forms: six forms.